Cardiac Dysfunction Induced by High-fat Diet is Associated with Altered Myocardial Insulin Signalling in Rats

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2005 May 3

PMID 15864533

Citations 91

Authors

D M Ouwens

C Boer

M Fodor

P de Galan

R J Heine

J A Maassen

M Diamant

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: Diabetic cardiomyopathy (DCM) is common in type 2 diabetes. In DCM, insulin resistance may alter cardiac substrate supply and utilisation leading to changes in myocardial metabolism and cardiac function. In rats, exposure to excessive alimentary fat, inducing a type 2 diabetic phenotype, may result in myocardial insulin resistance and cardiac functional changes resembling DCM.

Materials And Methods: Rats received high-fat (HFD) or low-fat (LFD) diets for 7 weeks. Prior to killing, insulin or saline was injected i.p. Contractile function and insulin signalling were assessed in papillary muscles and ventricular lysates, respectively.

Results: Fasting and post-load blood glucose levels were increased in HFD- vs LFD-rats (all p < 0.02). Mean heart weight, but not body weight, was increased in HFD-rats (p < 0.01). HFD-hearts showed structural changes and triglyceride accumulation. HFD-muscles developed higher baseline and maximum forces, but showed impaired recovery from higher workloads. Insulin-associated modulation of Ca2+-induced force augmentation was abolished in HFD-muscles. HFD reduced insulin-stimulated IRS1-associated phosphatidylinositol 3'-kinase activity and phosphorylation of protein kinase B, glycogen synthase kinase-3beta, endothelial nitric oxide synthase, and forkhead transcription factors by 40-60% (all p < 0.05). Insulin-mediated phosphorylation of phospholamban, a critical regulator of myocardial contractility, was decreased in HFD-hearts (p < 0.05).

Conclusions/interpretation: HFD induced a hypertrophy-like cardiac phenotype, characterised by a higher basal contractile force, an impaired recovery from increased workloads and decreased insulin-mediated protection against Ca2+ overload. Cardiac dysfunction was associated with myocardial insulin resistance and phospholamban hypophosphorylation. Our data suggest that myocardial insulin resistance, resulting from exposure to excessive alimentary fat, may contribute to the pathogenesis of diabetes-related heart disease.

Citing Articles

Exercise improves systemic metabolism in a monocrotaline model of pulmonary hypertension.

Poojary G, Vasishta S, Thomas R, Satyamoorthy K, Padmakumar R, Joshi M Sports Med Health Sci. 2024; 7(1):37-47.

PMID: 39649790 PMC: 11624410. DOI: 10.1016/j.smhs.2024.03.001.

PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy.

Chen X, Ruiz-Velasco A, Zou Z, Hille S, Ross C, Fonseka O Diabetes. 2024; 73(11):1805-1820.

PMID: 39137120 PMC: 11493761. DOI: 10.2337/db24-0240.

Dietary regimens appear to possess significant effects on the development of combined antiretroviral therapy (cART)-associated metabolic syndrome.

Chege B, Mwangi P, Githinji C, Bukachi F PLoS One. 2024; 19(2):e0298752.

PMID: 38416754 PMC: 10901320. DOI: 10.1371/journal.pone.0298752.

Relationship between four insulin resistance surrogates and left ventricular hypertrophy among hypertensive adults: a case-control study.

Zhai Y, Fu H, Li Y, Li S, Zhang W, Yue J Endocr Connect. 2024; 13(4).

PMID: 38300820 PMC: 10959039. DOI: 10.1530/EC-23-0476.

The role of polycystic ovary syndrome in preclinical left ventricular diastolic dysfunction: an echocardiographic approach: a systematic review and meta-analysis.

Mirzohreh S, Panahi P, Zafardoust H, Zavvar M, Fathi N, Dehghan M Cardiovasc Endocrinol Metab. 2023; 12(4):e0294.

PMID: 37900050 PMC: 10611352. DOI: 10.1097/XCE.0000000000000294.

References

Unger R . Lipotoxic diseases. Annu Rev Med. 2002; 53:319-36. DOI: 10.1146/annurev.med.53.082901.104057. View

Belke D, Swanson E, Dillmann W . Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes. 2004; 53(12):3201-8. DOI: 10.2337/diabetes.53.12.3201. View

Bell D . Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?. Diabetes Care. 1995; 18(5):708-14. DOI: 10.2337/diacare.18.5.708. View

Allard M, Wambolt R, Longnus S, Grist M, Lydell C, Parsons H . Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab. 2000; 279(3):E487-93. DOI: 10.1152/ajpendo.2000.279.3.E487. View

Doenst T, Goodwin G, Cedars A, Wang M, Stepkowski S, Taegtmeyer H . Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Metabolism. 2001; 50(9):1083-90. DOI: 10.1053/meta.2001.25605. View

Cazzolli R, Carpenter L, Biden T, Schmitz-Peiffer C . A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes. 2001; 50(10):2210-8. DOI: 10.2337/diabetes.50.10.2210. View

Vanninen E, Mustonen J, Vainio P, Lansimies E, Uusitupa M . Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am J Cardiol. 1992; 70(3):371-8. DOI: 10.1016/0002-9149(92)90622-6. View

Youngren J, Paik J, Barnard R . Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats. J Appl Physiol (1985). 2001; 91(5):2240-7. DOI: 10.1152/jappl.2001.91.5.2240. View

Murphy S, Frishman W . Protein kinase C in cardiac disease and as a potential therapeutic target. Cardiol Rev. 2004; 13(1):3-12. DOI: 10.1097/01.crd.0000124914.59755.8d. View

10.

Lamberts R, van Rijen M, Sipkema P, Fransen P, Sys S, Westerhof N . Coronary perfusion and muscle lengthening increase cardiac contraction: different stretch-triggered mechanisms. Am J Physiol Heart Circ Physiol. 2002; 283(4):H1515-22. DOI: 10.1152/ajpheart.00113.2002. View

11.

Fath-Ordoubadi F, Beatt K . Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997; 96(4):1152-6. DOI: 10.1161/01.cir.96.4.1152. View

12.

Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I . Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem. 2004; 279(39):40827-34. DOI: 10.1074/jbc.M405770200. View

13.

Korvald C, Elvenes O, Myrmel T . Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol. 2000; 278(4):H1345-51. DOI: 10.1152/ajpheart.2000.278.4.H1345. View

14.

Finck B, Lehman J, Leone T, Welch M, Bennett M, Kovacs A . The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002; 109(1):121-30. PMC: 150824. DOI: 10.1172/JCI14080. View

15.

Perseghin G, Petersen K, Shulman G . Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord. 2004; 27 Suppl 3:S6-11. DOI: 10.1038/sj.ijo.0802491. View

16.

Dutta K, Podolin D, Davidson M, Davidoff A . Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes. 2001; 50(5):1186-92. DOI: 10.2337/diabetes.50.5.1186. View

17.

Carvalheira J, Calegari V, Zecchin H, Nadruz Jr W, Guimaraes R, Ribeiro E . The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance. Endocrinology. 2003; 144(12):5604-14. DOI: 10.1210/en.2003-0788. View

18.

Abel E, Kaulbach H, Tian R, Hopkins J, Duffy J, Doetschman T . Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest. 1999; 104(12):1703-14. PMC: 409881. DOI: 10.1172/JCI7605. View

19.

Netticadan T, Temsah R, Kent A, Elimban V, Dhalla N . Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes. 2001; 50(9):2133-8. DOI: 10.2337/diabetes.50.9.2133. View

20.

Withers D, Ouwens D, Nave B, van der Zon G, Alarcon C, Cardenas M . Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. Biochem Biophys Res Commun. 1998; 241(3):704-9. DOI: 10.1006/bbrc.1997.7878. View